BIAF Dividend: bioAffinity Technologies Inc Yield Insights

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	7	9	2	0	0	0
Revenue Growth (YoY)	0%	350%	--	--	--	--
Cost of Revenue	5	5	1	0	--	--
Gross Profit	2	3	0	0	--	--
Selling, General & Admin	9	9	6	2	0	0
Research & Development	1	1	1	1	1	1
Operating Expenses	12	12	8	4	2	2
Other Non Operating Income (Expenses)	0	0	0	--	--	--
Pretax Income	-11	-9	-7	-8	-6	-7
Income Tax Expense	0	0	0	0	0	0
Net Income	-11	-9	-7	-8	-6	-7
Net Income Growth	38%	28.99%	-13%	33%	-14%	--
Shares Outstanding (Diluted)	0.8	0.4	0.29	0.15	0.09	0.09
Shares Change (YoY)	111%	39%	94%	65%	0%	--
EPS (Diluted)	-14.59	-22.36	-27.22	-54.35	-69.62	-79.96
EPS Growth	-37%	-18%	-50%	-22%	-13%	--
Free Cash Flow	-7	-7	-6	-4	-2	-2
Free Cash Flow Per Share	-8.74	-17.32	-20.58	-26.66	-22	-22
Gross Margin	28.57%	33.33%	0%	0%	--	--
Operating Margin	-142.85%	-88.88%	-350%	0%	0%	0%
Profit Margin	-157.14%	-100%	-350%	0%	0%	0%
Free Cash Flow Margin	-100%	-77.77%	-300%	0%	0%	0%
EBITDA	-10	-8	-7	-4	-2	-2
EBITDA Margin	-142.85%	-88.88%	-350%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-10	-8	-7	-4	-2	-2
EBIT Margin	-142.85%	-88.88%	-350%	0%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

bioAffinity Technologies Inc (BIAF) Price